ArticleTherapeutic advances in hematology2023

Low-dose decitabine for previously untreated acute myeloid leukemia ineligible for intensive chemotherapy aged 65 years or older: a prospective study based on comprehensive geriatric assessment.

Ru Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.